NCT01021163View on ClinicalTrials.gov

Effects of N-acetylcysteine on Pulmonary Function in High-risk Patients Undergoing Off-pump Coronary Bypass Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

Not specified

Conditions
Coronary Artery Occlusion
Interventions
DRUG

N-acetylcysteine, saline

Inject 100 mg/kg of N-acetylcysteine or the equivalent amount of saline for 15 minutes before the skin incision, then continuously inject 40 mg/kg/day of N-acetylcysteine or the equivalent amount of saline during the next 24 hours.

Trial Locations (1)

Unknown

Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01021163 - Effects of N-acetylcysteine on Pulmonary Function in High-risk Patients Undergoing Off-pump Coronary Bypass Surgery | Biotech Hunter | Biotech Hunter